Also from this source

You just read:

Forty Seven, Inc. Announces Proof-of-Concept Data from Two Clinical Trials of 5F9 In Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphoma

News provided by

Forty Seven, Inc.

Jun 03, 2018, 08:00 ET